MOR GEORGE ADI (Chief Executive Officer) sold 6.6% of their position (9.80K shares) of CHEMOMAB THERAPEUTICS LTD. on the open market
Open‑market sale worth $20.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/1/2026ACC: 0001178913-26-003004
DirectorOfficer10% Owner· Chief Executive Officer
Since Mar 2021
-60.27K
Net shares
Net seller
$20.2K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
60.27K disposed
Non-Derivative Transactions4
American Depositary Shares
Direct
Shares
−4.88K
Price / share
$2.05
Trade value
$10K
% of position
3.5%
5/29/2026
139.08K→134.21K
American Depositary Shares
Direct
Shares
−4.93K
Price / share
$2.08
Trade value
$10.25K
% of position
3.4%
5/29/2026
144.06K→139.13K
American Depositary Shares
Direct
Shares
−31.71K
Price / share
—
Trade value
—
% of position
50.0%
5/29/2026
63.42K→31.71K
American Depositary Shares
Direct
Shares
−18.75K
Price / share
—
Trade value
—
% of position
50.0%
5/29/2026
37.50K→18.75K
Total
Net shares
−60.27K
Net value
-$20.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| American Depositary Shares Direct | 5/29/2026 | P · Purchase | −4.88K | $2.05 | $10K | 3.5% | 139.08K | 134.21K |
| American Depositary Shares Direct | 5/29/2026 | P · Purchase | −4.93K | $2.08 | $10.25K | 3.4% | 144.06K | 139.13K |
| American Depositary Shares Direct | 5/29/2026 | J · J | −31.71K | — | — | 50.0% | 63.42K | 31.71K |
| American Depositary Shares Direct | 5/29/2026 | J · J | −18.75K | — | — | 50.0% | 37.50K | 18.75K |
| Total | −60.27K | -$20.25K | ||||||
Derivative Transactions0
No derivative transactions reported